Amerise Biosciences Ratios

Amerise Biosciences Ltd Ratios

The Amerise Biosciences Ltd Ratios page provides a complete fundamental analysis of Amerise Biosciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Amerise Biosciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Amerise Biosciences Ltd (NSE: , BSE: 531681) is currently trading at ₹0.72, with a market capitalization of ₹44.93M. As a major player in the Finance sector and Financial conglomerates industry, Amerise Biosciences Ltd remains a key stock for fundamental analysis using Amerise Biosciences Ltd Ratios.

Amerise Biosciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Amerise Biosciences Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Amerise Biosciences Ltd Ratios.

Historically, the Amerise Biosciences Ltd P/E ratio has shown strong fluctuations:

The decline in Amerise Biosciences Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Amerise Biosciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Amerise Biosciences Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Amerise Biosciences Ltd P/S ratio currently stands at 0, an important part of Amerise Biosciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Amerise Biosciences Ltd P/S ratio indicates cautious market sentiment.

Amerise Biosciences Ltd Price to Cash Flow Ratio (P/CF)

The Amerise Biosciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Amerise Biosciences Ltd Price to Cash Flow Ratio:

The declining Amerise Biosciences Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Amerise Biosciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Amerise Biosciences Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Amerise Biosciences Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Amerise Biosciences Ltd EV/EBITDA ratio is currently 0, a key metric in Amerise Biosciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Amerise Biosciences Ltd EV/EBITDA indicates balanced valuation.

Amerise Biosciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Amerise Biosciences Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Amerise Biosciences Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Amerise Biosciences Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Amerise Biosciences Ltd Ratios Analysis Summary

The Amerise Biosciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Amerise Biosciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Amerise Biosciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.